Skip to main content

Table 1 Characteristics of Subjects at enrollment*

From: No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial

Characteristics

Placebo (n = 7)

Epoprostenol (n = 7)

Male gender

4 (57)

4 (57)

Age, yr

54.4 (19.9)

55.3 (18.2)

Weight, kg

78.9 (11.2)

74.0 (9.7)

RVED, cm

4.1 (0.84)

4.1 (0.83)

Systolic PAP, mmHg

47 (10.6)

57 (13.9)

Right ventricle free wall diameter, mm

6.1 (0.7)

5.9 (0.9)

NT-proBNP, pg/ml

1467 (39-8549)

3885 (270-12339)

Troponin T, ng/ml

0.01 (0.01-0.13)

0.03 (0.01-0.12)

PaO2, mmHg

85 (14)

74 (12)

  1. Definition of abbreviations: PAP = pulmonary artery pressure; RVED = right ventricular end-diastolic diameter; PaO2 = partial arterial oxygen pressure
  2. *Data are presented as No. (%) or mean (SD). NT-proBNP and troponin T are presented as median (range)